News
Public · Published
Kodiak Sciences Inc. reports results for the quarter ended September 30 - Earnings Summary
Kodiak Sciences reported an adjusted loss of $1.05 per share for the quarter ended September 30, compared with a larger per-share loss in the same quarter last year. Revenue was zero, matching analyst expectations, and the company reported a quarterly loss of $66.22 million.
Published:
Updated:
What happened
Kodiak Sciences reported an adjusted loss of $1.05 per share for the quarter ended September 30, compared with a larger per-share loss in the same quarter last year. Revenue was zero, matching analyst expectations, and the company reported a quarterly loss of $66.22 million.
Confirmed
Global impact / market context
The results show Kodiak had no revenue while continuing to record a substantial quarterly loss, so the company’s reported performance depends on spending and funding rather than sales. The smaller per-share loss than a year earlier may ease concern, but does not establish a path to revenue.
Analyst inference
Analysts had expected a $1.06 per-share loss, close to the reported $1.05 loss, while their average earnings estimate had fallen about 12.9% over three months. Shares were up 291.1% year to date, and the average analyst rating was buy, indicating a high bar for future results.
Analyst inference
What to watch
- Watch for quarterly revenue, since it was zero this period; any move toward sales would show whether Kodiak can begin offsetting costs with income from its business. Analyst inference
- Compare future losses and loss per share with this quarter’s $66.22 million loss and $1.05 adjusted loss per share to see whether spending pressure is changing. Analyst inference
- Analysts had made no earnings estimate revisions in the last 30 days; new revisions could indicate whether expectations are adjusting after the reported results. Confirmed
Evidence
- Original source link unavailable